Zebrafish Bioassay-Guided Natural Product Discovery: Isolation of Angiogenesis Inhibitors from East African Medicinal Plants

A critical analysis of current in vitro and in vivo angiogenesis assays

(2010) Carolyn A. Staton et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials

(2010) Toni K. Choueiri et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies

(2009) Annamaria Rapisarda et al.   DRUG RESISTANCE UPDATES

The use ofin vivozebrafish assays in drug toxicity screening

(2009) Peter M Eimon et al.   Expert Opinion on Drug Metabolism & Toxicology

Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way

(2009) Peter Carmeliet et al.   Nature Reviews Clinical Oncology

An overview of small-molecule inhibitors of VEGFR signaling

(2009) S. Percy Ivy et al.   Nature Reviews Clinical Oncology

Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance

(2009) Yihai Cao et al.   SEMINARS IN CANCER BIOLOGY

Zebrafish: a predictive model for assessing drug-induced toxicity

(2008) Patricia McGrath et al.   DRUG DISCOVERY TODAY

Anti-angiogenic effects of rhubarb and its anthraquinone derivatives

(2008) Zhi-Heng He et al.   JOURNAL OF ETHNOPHARMACOLOGY

Antiangiogenic activity of Tripterygium wilfordii and its terpenoids

(2008) Ming-Fang He et al.   JOURNAL OF ETHNOPHARMACOLOGY

Fishing for Drugs from Nature: Zebrafish as a Technology Platform for Natural Product Discovery

(2008) Alexander Crawford et al.   PLANTA MEDICA

Identification of a Novel Retinoid by Small Molecule Screening with Zebrafish Embryos

(2008) Chetana Sachidanandan et al.   PLoS One